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on walking efficiency in patients with
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Jørn Heggelund1,2,3*, Gunnar Morken1,3, Jan Helgerud4,5,6, Geir E Nilsberg3† and Jan Hoff4,7†Abstract
Background: Patients with schizophrenia frequently have disabling gait deficits. The net mechanical efficiency of
walking (Enet) is an accurate measure often used to evaluate walking performance. Patients with gait deficits have a
reduced Enet with excessive energy expenditure during sub-maximal walking. Maximal strength training (MST)
improves Enet in healthy individuals and is associated with reduced risk of mortality. The aim of this study was to
investigate whether MST improves Enet in patients with schizophrenia.
Methods: Patients (ICD-10 schizophrenia, schizotypal or delusional disorders (F20-F29)) were included in a
non-randomized trial. Patients were assigned to one of two groups: 1) MST consisting of 4x4 repetitions at 85-90%
one repetition maximum (1RM) performed in a leg press apparatus or 2) playing computer games (CG). Both
groups carried out their activity three days per week for eight weeks. 1RM, Enet at 60 watt walking, peak oxygen
uptake (VO2peak), the Positive and Negative Syndrome Scale (PANSS) and the 36-items short form (SF-36) were
measured pre and post intervention.
Results: The baseline Enet was 17.3 ± 1.2% and 19.4 ± 3.0% in the MST (n = 6) and CG groups (n = 7), respectively,
which is categorized as mechanical inefficiency. The MST group improved 1RM by 79 kg (p= 0.006) and Enet by
3.4% (p= 0.046) more than the CG group. The MST group improved 1RM and Enet, by a mean of 83 kg
(p= 0.028) and 3.4% (p= 0.028), respectively. VO2peak at baseline was 34.2 ± 10.2 and 38.3 ± 9.8 mlkg-1min-1 in
the MST and CG groups, respectively, and did not change (p> 0.05). No change was observed in PANSS or
SF-36 (p> 0.05).
Conclusions: MST improves 1RM and Enet in patients with schizophrenia. MST could be used as a therapeutic
intervention for patients with schizophrenia to normalize their reduced Enet.
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Patients with schizophrenia frequently have disabling
gait deficits. Often the patients have decreased walking
speed, reduced stride length and balance deficits [1,2].
Gait deficits occur independently of the side effects of
antipsychotic medication, but conventional antipsychotic
treatment seems to worsen it [1]. Gait deficits influence* Correspondence: Jorn.Heggelund@ntnu.no
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antipsychotic treatment [3,4].
Net mechanical efficiency of walking (Enet) is a common
physiological method used to evaluate walking and the
metabolic consequences of gait deficits. This measure
determines the magnitude of metabolic energy expend-
iture converted into mechanical work during walking. Gait
deficits such as those in Parkinson’s disease increase the
metabolic cost of walking and reduce Enet [5]. Conse-
quently, patients with poor Enet use excessive amounts of
energy to sustain a given sub-maximal workload, which
contributes to an elevated level of physical fatigue.
Findings from our lab indicate that Enet is reduced intral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.












Male/Female, N 1/5 4/3 0.266c
Age, year 37.5 ± 9.6 38.9 ± 11.4 1.000
Age at first contact with
psychiatric services, year
23.5 ± 7.7 25.2 ± 6.3 0.836
Months of hospitalization 107.5 ± 58.6 70.0 ± 62.9 0.366
Height, cm 162 ± 10 175 ± 10 0.051
Body weight pre-intervention, kg 81.2 ± 32.2 85.3 ± 29.7 1.000
Body weight post-intervention, kg 82.5 ± 30.8 87.1 ± 29.9 0.945
Body mass index pre-intervention,
kgm-2
30.7 ± 11.2 27.6 ± 8.5 0.628
ICD-10 diagnosis, N
Paranoid schizophrenia 2 4 0.592c
Disorganized schizophrenia 1
Undifferentiated schizophrenia 2 2
Unspecified schizophrenia 1
Schizoaffective disorder 1
Use of neuroleptics, N










aData is presented as mean ± standard deviation.
bMan-Whitney U Test.
cFisher’s exact test.
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training program [6].
Patients with poor Enet, such as those with coronary ar-
tery disease and peripheral arterial disease, have derived
benefit from lower limb maximal strength training
(MST) [7-9]. MST aims to increase the ability to lift the
highest possible weight in one repetition (1RM) and the
ability to produce high forces at great speed. These
adaptations have shown significant impacts in rehabilita-
tion programs owing to their carry-over effects on
walking performance measured as Enet [8,10,11]. MST
also has a number of beneficial effects, such as increased
basal metabolic rate, improved glucose metabolism and
improved cholesterol levels, that could reduce the high
risk of cardiovascular disease and metabolic syndrome in
patients with schizophrenia [12,13]. Strength training is
scarcely investigated in patients with schizophrenia and
no studies have investigated the effects of strength
training on Enet in patients with schizophrenia.
The objective in this pilot-study was to evaluate effects
of 8 weeks MST on 1RM, Enet, symptoms of schizophrenia
and quality of life. We chose to compare the MST with in-
activity in the form of playing a computer game (CG) over
the same number of sessions. We hypothesized that MST
would improve 1RM and Enet more than inactivity (CG).
Methods
Study design
A controlled pilot study with pre-post intervention design
was carried out. One group performed MST and one
group spent the same amount of time playing computer
games (CG). A non-randomized trial design was incorpo-
rated in this pilot study in order to prevent distrust of
patients due to randomization and to avoid excluding the
most severely ill patients [14]. The sample size estimate
was based on the results of mechanical efficiency from a
similar study showing a 3.4% mean difference in change
between groups with a 95% CI (−0.01 to 6.8). The change
was significant (p< 0.05) using a Mann–Whitney U test
and 6 patients in each group [10]. The CG group also
serves as a control group in another study [6]. All included
patients were considered suitable for participation in both
interventions. We first included patients to the CG group
and then to the MST group. All patients performed pre
and post tests and a supervised intervention three times
per week in 8 weeks. The outcome assessment was not
blinded. To avoid experimenter bias the planned test
protocol was exactly adhered to in both groups.
Patients
Patients were in- and outpatients at the University
Hospital psychiatric department. All patients lived under
supervised conditions. To be included, patients had to
have ICD-10 schizophrenia, schizotypal or delusionaldisorders (F20-F29). Patients were excluded if they had
coronary heart disease, chronic obstructive pulmonary
disease, any major changes in pharmacological treatment
during the intervention period, were unable to perform
testing, or adhered to less than 19 training sessions
(80%). Included patients did not perform strength
training or play computer games outside of the study.
The patients’ traditional therapy was unchanged during
the intervention period. All patients took neuroleptics
(Table 1). To clarify inclusion/exclusion criteria and
somatic health a medical doctor performed a health
examination at the beginning of the study. Diagnoses
were confirmed by medical records. Sixteen patients
were included, the first nine were assigned to CG and
the next seven patients were assigned to MST. There
were 5 in-patients included in the study, all of them in
the CG group. Three patients did not complete the
training period: in the CG group one patient was dis-
charged from the hospital before completion and one
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excluded because the patient completed less than 80% of
the training sessions. No acute psychotic episodes were
registered during the intervention. The study was
approved by the National Committee for Medical and
Health Research Ethics (REK Midt) and was conducted
according to the Helsinki declaration. Written informed
consent was obtained from all the included patients after
the procedures were fully explained. Characteristics of
the patients are presented in Table 1.
Interventions
All MST sessions started with a five minute warm-up on
the treadmill at a workload corresponding to 70% of
peak heart rate (HRpeak; the highest heart rate measured
during the last minute of the peak oxygen uptake
(VO2peak) test). MST was then performed at a 54˚ in-
cline leg press machine (Technogym, Italy). The weight
was lowered in a controlled manner in the eccentric
phase until the patient reached 90 degrees in the knee
joint. Then the patients had a short stop (~0.5 second)
before the weight was moved as rapidly as possible to
complete extension. The training volume was four sets
of four repetitions with a load corresponding to 85-90%
1RM. An exercise physiologist supervised the training
sessions and ensured that the training load was
increased with 2.5-5 kg each time patients managed to
perform four sets with the determined load. Rest periods
were three minutes between each set.
The CG group spent 36 minutes three times per week
training to improve their ability in the computer game
Tetris (THQ Inc. Calabasas Hills, CA), using an Xbox
Video Game Systems (Microsoft Corporation, Redmond,
USA). All sessions were monitored and patients were
encouraged to improve performance.
Interventions were performed in the hospital’s physical
training facilities, with easy access for patients and staff.
MST and CG was performed in separate rooms. Mem-
bers of the staff were dedicated to implement the inter-
ventions as an integrated part of the treatment program.
Outcome measurements
Physical testing started with a ten minute warm-up at
the treadmill at approximately 50-60% of VO2peak.
Patients then performed a six minute sub maximal walk
on the DKCity treadmill (Tung Keng Enterprise CO.,
LTD. Taiwan) at a load corresponding to 60 watt (60
Newton meters per second, 60 N  m  sec-1) and
without holding onto the handrails. The speed and
inclination at 60 watt was calculated from the bodymass
(mb) in kilo and elevation on the treadmill using Equa-
tion (1). The speed range used in the calculation was
three to six kilometers per hour (kmh-1) and the eleva-
tion was adjusted accordingly. Sin θ is the sinus to theangle of elevation on the treadmill.
km  h1 ¼ 60N m  sec
1
mb  9:81Nð Þ  sinθ  3:6km  h
1 ð1Þ
The measurements of pulmonary gas exchange were
obtained between 5 and 5.5 minutes walking, using the
Cortex Metamax II portable metabolic test system
(Cortex Biophysik GmbH, Leipzig, Germany). Heart rate
was assessed concurrently using a Polar S610i heart rate
monitor (Polar Electro, Finland). Enet was determined as
the percentage of the work input (kilocalories) that is
converted into work output, as presented in Equation
(2). _W is the steady power produced during walking,
expressed as the Watt production converted into
kilocalories per minute (Watt  0.01433 Kcalmin-1). The
net metabolic rate (Ėnet) is kilocalories per minute
estimated from the net oxygen consumption and the
caloric value of the corresponding respiratory quotient
(RQ). The net oxygen consumption is calculated by
deducting the estimated resting oxygen consumption
(3.5 mLkg-1min-1) and the horizontal component of
walking (0.1 mLkg-1min-1) [15] from the total oxy-





Immediately after testing Enet, the patients proceeded
with the VO2peak testing protocol. The speed or the in-
clination was increased every minute until the patient
was no longer able to continue, preferentially within
3–6 min. VO2peak was accepted when VO2 leveled off
despite further increases in speed and when respiratory
exchange ratio (RER) was above 1.10 [16]. The highest
heart rate recorded during the last minute of the test
was determined as HRpeak.
1RM was measured on the leg press machine using
Olympic weights (Eleiko, Sweden). The lift was per-
formed from complete extension to 90 degrees angle in
the knee joint and back to complete extension. The load
was increased successively until the patient was not able
to lift the weight. Test procedures were carefully
explained to the patients.
Symptoms of schizophrenia were assessed with the Posi-
tive and Negative Syndrome Scale (PANSS) [17]. The 36-
item short form (SF-36) self-report instrument was used
to assess the physical health and mental health aspect of
health related quality of life [18]. SF-36 scales are found to
be reliable for patients with schizophrenia [19].
Statistical methods
Data are expressed as mean and standard deviations (SD)
unless otherwise noted. A related samples Wilcoxon test
was used to determine changes from pre to post
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test was used to evaluate the changes and differences be-
tween groups. Categorical variables were tested using
Fisher’s exact test. The significance level was set at p <0.05
(2-tailed). Statistical analyses were performed using the
software program SPSS, version 17.0 (Statistical Package
for Social Science, Chicago, IL).
Results
Patients in the MST (n = 6) and CG (n = 7) groups per-
formed a mean of 85 ± 9% and 83 ± 6% of the scheduled
training sessions, respectively. One patient in the CG
group refused to execute maximal strength testing in the
leg press machine. Apart from this missing test, the
patients performed all of the planned tests.
The two groups did not differ pre-intervention with
regard to 1RM (p= 0.357), Enet (p= 0.063), VO2peak
(p= 0.253), total PANSS (p= 0.517) and SF-36 scores
(physical health score: p= 0.749, mental health score:
p= 0.200). During eight weeks of training, the MST
group improved mean 1RM by 79 kg more than the CG
group (p= 0.006). The MST group improved 1RM with
83 kg (p= 0.028), from mean 218 ± 45 kg to 301 ± 65 kg
while the CG group did not change from pre-
214 ± 100 kg to post-intervention 218 ± 97 (p = 0.465).
Enet improved by 3.4% more in the MST group than in
the CG group (p= 0.046; Table 2). The improvement in
Enet within the MST group was 3.4% (p= 0.028; Table 2).
No change was observed in the CG group (p > 0.999).
Changes in 1RM and Enet from pre- to post-intervention
are presented as percent changes in Figure 1. The VO2
cost of walking at 60 watt was also reduced for the MST
group after the intervention (p= 0.028), but not for the
CG (p= 0.0176; Table 2). The VO2 reduction in the MST
group was not significantly larger than in the CG
(p= 0.063), but was supported by a grater reduction in
pulmonary ventilation (p= 0.032) and the respiratory ex-
change ratio (p= 0.031) in the MST group. No changesTable 2 Physiological variables measured during 60 Watt con
Maximal strengt
training (n = 6)
Pre P
Net mechanical efficiency of walking (Enet), % 17.3 ± 1.2 20.7 ±
Oxygen uptake
Lmin-1 1.71 ± 0.38 1.60 ±
mlkg-1min-1 22.0 ± 3.1 20.0 ±
HR, beatsmin-1 143± 9 137±
VE, Lmin-1 44.9 ± 12.2 39.9 ±
RER 0.95 ± 0.06 0.90 ±
aData is presented as mean ± standard deviation. HR: heart rate, VE: total pulmonary
bdifferences within groups from pre to post intervention (p< 0.05).
cdifferences in change between groups (p< 0.05).were observed from pre to post-intervention in VO2peak
in either group or between the groups (p > 0.05). Pre-
and post-intervention VO2peak was 34.2 ± 10.2 and
32.3 ± 8.5 mlkg-1min-1 in the MST and 38.3 ± 9.8 and
37.9 ± 9.9 mlkg-1min-1 in the CG group.
No significant changes were observed from pre- to
post-intervention in the two groups in total PANSS
(MST: p= 0.115, CG: p= 0.753), SF-36 physical health
score (MST: p= 0.173, CG: p= 0.116) or mental health
score (MST: p= 0.463, CG: p= 0.345). There were no dif-
ferences in changes between groups (total PANSS:
p= 0.086, physical health score: p= 0.688, mental health
score: p= 0.262). The pre-intervention mean total PANSS
score was 58 ± 12 and 63 ± 20 in the MST and CG groups
respectively. The mean post-intervention PANSS scores
was 68 ± 8 and 61 ± 19, in MST and CG groups
respectively. The SF-36 mean physical health scores at
pre- and post- intervention, were 45 ± 10 and 51 ± 11 in
the MST group and 46 ± 8 and 48 ± 6 in the CG group,
respectively. The mean mental health scores at pre- and
post-intervention, were 36 ± 5 and 35 ± 8 in the MST
group and 45 ± 11 and 48 ± 2 in the CG group,
respectively.
Discussion
The findings indicate that patients with schizophrenia
could safely participate in maximal strength training
with a beneficial improvement in maximal strength and
walking performance due to improved Enet. These
improvements occurred without affecting symptoms of
schizophrenia.
The MST group improved their 1RM in incline leg
press by 38%. This level of improvement is comparable
with findings from studies investigating MST in patients
with heart disease, chronic obstructive pulmonary
disease, healthy subjects and distance runners. Improve-
ments ranging from 27 to 44% have been reported after





ost Pre Post Mean (SE)
2.9 b 19.4 ± 3.0 19.4 ± 2.5 3.4 (1.6) c
0.37 b 1.77 ± 0.49 1.77 ± 0.45 −0.12 (0.06)
2.9 b 21.5 ± 3.5 21.1 ± 3.2 −1.5 (0.7)
12 136 ± 17 133± 11 −4 (5)
12.2 b 45.5 ± 15.7 44.8 ± 12.8 −4.4 (1.7) c
0.06 b 0.93 ± 0.04 0.92 ± 0.04 −0.04 (0.01) c































Figure 1 Percent changes in one repetition maximum (1RM)
and net mechanical efficiency of walking. MST, maximal strength
training; CG, playing computer games. bdifferences from pre to post
intervention (p< 0.05). cdifferences in change between groups
(p< 0.05).
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schizophrenia are able to participate in strength
training and improve their 1RM. The improvement
in 1RM occurred without changes in bodyweight.
The MST group improved Enet significantly more than
the CG group. This is in agreement with the strength
training studies that have addressed effects on endurance
performance. Although clinically significant, the 20% im-
provement in Enet is somewhat smaller compared to
32-35% improvement found in other patient groups [8,10].
This might indicate that factors associated with the illness
itself or side effects from antipsychotic medication may
hamper the transfer effect from improved 1RM to
improved Enet. As expected, the VO2peak did not change.
Maximal strength training mainly results in neural system
adaptations with improved maximal strength and ability
to develop speed. MST does not result in cardiovascular
system changes such as increased peak stroke volume and
increased VO2peak [7]. However, increased VO2peak from
endurance training is often followed by improved Enet [6].
In this respect, the improved Enet in this study is
considered being a result of the MST intervention, not
confounded by increased VO2peak. On the contrary, the
mean VO2peak in the MST group worsened in absolute
terms. The most plausible explanation is that patients
could have reduced their endurance physical activities
during the intervention. No outside intervention activity
control were carried out.
The initial Enet of 17.3% (MST) and 19.4% (CG) can be
considered low and within the range of patients that
walk with mechanical inefficiency [8,22]. The Enet values
in the present study are similar to values found in
patients with coronary artery disease (19.2%) and lowerthan in healthy controls (24.7%) [22]. Gait deficits in
schizophrenia have been reported, with the poorest gait
patterns found in patients treated with conventional
antipsychotics [1]. Patients with schizophrenia choose to
walk slower (2.7 to 3.1 kmh-1), compared to healthy
controls (3.4 kmh-1) [1]. From a metabolic point of
view, it seems natural that the patients would walk
slower if they had lower VO2peak and poorer Enet.
Walking is usually undertaken at a speed that coincides
with the lowest metabolic cost. Poor Enet might be an
obstacle in performing daily tasks and so might prevent
patients from engaging in activities that require walking.
Additionally, poor Enet as well as other gait deficits might
have implications for the patients’ well-being [3]. Of
interest, the MST improved Enet to a level that is closer
to healthy individuals [8,22].
Our study revealed no changes in the total PANSS
score or SF-36. In absolute terms, there was an increase
of 10 points in the MST group and a decrease of 2
points in the CG group on the total PANSS score. As
there are no reasons to anticipate an adverse effect from
MST, as would be reflected by an increase in PANSS
score, we believe this tendency of a change is due to
natural variations in the course of the illness and is
probably valid for patients with schizophrenia. There is a
small sample size in this study and other mediators or
moderators such as depression, anxiety or fatigue due to
the intervention were not measured. There are few
reports of strength training on symptoms of schizophrenia.
A single-group study found that patients reported im-
provement in a questionnaire that measured perceived
psychological well being, but no improvement in the Zung
Self Rating Depression Scale (SDS), after weight lifting
therapy [21]. A case study described some improvements
in Brief Psychiatric Rating Scale (BPRS) and the Nurses’
Observational Scale for In-Patient Evaluation (NOSIE 30).
The patient showed beneficial behavior changes in his daily
activities. However, there is a need for larger scale and
longitudinal intervention studies to determine whether
strength training has the ability to decrease symptoms of
schizophrenia. Considering the effect of MST on Enet this
seems to be sufficient reason to include MST in the treat-
ment of schizophrenia. Furthermore, patients with
schizophrenia have a high risk of dying from cardio-
vascular disease [23]. The 8-weeks training period
performed in this study may not be sufficient to
affect traditional measures of cardiovascular disease.
Further studies should consider a longer period to in-
vestigate effects on common blood values. Patients
who maintain a certain level of maximal strength
through life may have a better chance of sustaining
good health. A prospective cohort study of 8762 men
aged from 20–80 years, found that maximal strength
was independently and inversely associated with all-
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after adjusting for cardiorespiratory fitness.
There are some limitations in this study. First, the allo-
cation of patients was not randomized. Thus, a selection
bias cannot be ruled out. To reduce the selection bias
we ensured that all patients were eligible for both inter-
ventions. None of the patients were selected because
they fitted one of the groups more than the other.
Patients were not able to choose a particular group, but
their personal preference for the intervention they were
asked to participate in could have influenced their deci-
sion. A possible disadvantage of the non-randomized
design is disclosed in the fact that the MST tend to
be hospitalized longer, younger at first contact with
psychiatric services and include more women. It could
be hypothesized that both severity of illness and gender
influenced baseline characteristics such as the SF-36, Enet
and VO2peak. On the contrary, the effects of the inter-
ventions might not be very different between genders.
However, the objective of this study was to evaluate the
effects of the intervention those might not be different
between genders. Although the outcome assessments
were not blinded, all tests followed strict procedures and
patients seemed to be motivated to perform their best
regardless of the group. The effect of the intervention
can only be generalized to patients that adhere to MST.
The study also had a small sample size. This might be
one reason for the tendency of a worsening of PANSS
symptoms in the MST group. Furthermore, the 8-week
intervention might be too short a period of time for
patients suffering from schizophrenia to adapt to the
intervention.Conclusions
The current study found that the MST improved the
patients 1RM to the same level as has been observed in
other patient groups and in healthy controls. The MST
did also improve the patients’ ability to normalize the
net mechanical efficiency of walking. MST is a safe and
effective intervention to improve 1RM and net mechanical
efficiency of walking in patients with schizophrenia.
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